{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:05:12Z","timestamp":1789473912246,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.idnow.2022.03.001","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T04:20:34Z","timestamp":1646713234000},"page":"252-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Utilization of macrolides. State of the art 2022 Spilf and GPIP"],"prefix":"10.1016","volume":"52","author":[{"given":"J.P.","family":"Stahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Castan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Bru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Diamantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Faye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hitoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lesprit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Maulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Poitrenaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Strady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Verdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vuotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Welker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gauzit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2022.03.001_bib0235","series-title":"Consommation d\u2019antibiotiques en secteur de ville en France de 2009 \u00e0 2019. Synth\u00e8se des indicateurs mis en ligne sur G\u00e9odes","author":"Cavali\u00e9","year":"2020"},{"key":"10.1016\/j.idnow.2022.03.001_bib0240","series-title":"Macrolides, Chemistry, Pharmacology and Clinical Uses","author":"Bryskier","year":"1993"},{"key":"10.1016\/j.idnow.2022.03.001_bib0245","series-title":"Macrolides\u2013Lincosamides\u2013Streptogramines in Antibiogramme by Courvalin, Bingen, Leclercq","first-page":"299","author":"Leclercq","year":"2012"},{"key":"10.1016\/j.idnow.2022.03.001_bib0250","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.tibs.2018.06.011","article-title":"How macrolide antibiotics work","volume":"43","author":"V\u00e1zquez-Laslop","year":"2018","journal-title":"Trends Biochem Sci"},{"issue":"12 Suppl 2","key":"10.1016\/j.idnow.2022.03.001_bib0255","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1093\/jac\/dkab175","article-title":"Consumption of macrolides, lincosamides and streptogramins in the community, European Union\/European Economic Area, 1997-2017","volume":"76","author":"Adriaenssens","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2022.03.001_bib0260","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1093\/jac\/dkab232","article-title":"Macrolide-associated ototoxicity: a cross-sectional and longitudinal study to assess the association of macrolide use with tinnitus and hearing loss","volume":"76","author":"Vanoverschelde","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2022.03.001_bib0265","first-page":"CD011825","article-title":"Adverse events in people taking macrolide antibiotics versus placebo for any indication","volume":"1","author":"Hansen","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idnow.2022.03.001_bib0270","unstructured":"Varon E, et al. Centre National de R\u00e9f\u00e9rence des Pneumocoques, Rapport annuel d\u2019activit\u00e9 2020. http:\/\/www.cnr-pneumo.com\/docman\/rapports\/46-2020-epidemiologie-2018-2019\/file. Consult\u00e9 le 8 d\u00e9cembre 2021."},{"key":"10.1016\/j.idnow.2022.03.001_bib0275","series-title":"Centre National de R\u00e9f\u00e9rence des streptocoques. Rapport annuel d\u2019activit\u00e9 2019","author":"Plainvert","year":"2019"},{"key":"10.1016\/j.idnow.2022.03.001_bib0280","unstructured":"Bebear C, Bercot B, Dupin N. Centre National de R\u00e9f\u00e9rence des Infections Sexuellement Transmissibles bact\u00e9riennes. Rapport annuel d\u2019activit\u00e9 2020. http:\/\/www.cnr-ist.fr\/ressources\/editeur\/2020\/RAPPORT_CNR_IST. Consult\u00e9 le 8 d\u00e9cembre 2021."},{"key":"10.1016\/j.idnow.2022.03.001_bib0285","series-title":"Centre National de R\u00e9f\u00e9rence des Campylobacters et des H\u00e9licobacters. Rapport annuel d\u2019activit\u00e9","author":"Lehours","year":"2021"},{"key":"10.1016\/j.idnow.2022.03.001_bib0290","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/147323000303100108","article-title":"Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease","volume":"31","author":"Bevan","year":"2003","journal-title":"J Int Med Res"},{"key":"10.1016\/j.idnow.2022.03.001_bib0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.AOG.0000268801.90261.27","article-title":"Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial","volume":"110","author":"Savaris","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.idnow.2022.03.001_bib0300","first-page":"549","article-title":"Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial","volume":"57","author":"Malhotra","year":"2003","journal-title":"Indian J Med Sci"},{"issue":"8","key":"10.1016\/j.idnow.2022.03.001_bib0305","article-title":"Antibiotic therapy for pelvic inflammatory disease","volume":"20","author":"Savaris","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idnow.2022.03.001_bib0310","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0956462417744099","article-title":"2017 European guideline for the management of pelvic inflammatory disease","volume":"29","author":"Ross","year":"2018","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.idnow.2022.03.001_bib0315","doi-asserted-by":"crossref","first-page":"101714","DOI":"10.1016\/j.jogoh.2020.101714","article-title":"Pelvic inflammatory diseases: update French guidelines","volume":"49","author":"Brun","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.idnow.2022.03.001_bib0320","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/cid\/cix669","article-title":"2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea","volume":"65","author":"Shane","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2022.03.001_bib0325","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ajg.2016.126","article-title":"ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults","volume":"111","author":"Riddle","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"Suppl. 1","key":"10.1016\/j.idnow.2022.03.001_bib0330","first-page":"S57","article-title":"Guideline for the prevention and treatment of travellers\u2019 diarrhea: a graded expert panel report","volume":"24","author":"Riddle","year":"2017","journal-title":"J Travel Med"},{"key":"10.1016\/j.idnow.2022.03.001_bib0335","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/510589","article-title":"Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen","volume":"44","author":"Tribble","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2022.03.001_bib0340","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(17)33296-8","article-title":"Shigellosis","volume":"391","author":"Kotloff","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.idnow.2022.03.001_bib0345","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","article-title":"Cholera","volume":"379","author":"Harris","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.idnow.2022.03.001_bib0350","article-title":"Antimicrobials for treating symptomatic non- typhoidal Salmonella infection","volume":"11","author":"Onwuezobe","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idnow.2022.03.001_bib0355","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/CMR.00002-15","article-title":"Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive salmonella infections","volume":"28","author":"Crump","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idnow.2022.03.001_bib0360","doi-asserted-by":"crossref","first-page":"101946","DOI":"10.1016\/j.tmaid.2020.101946","article-title":"Typhoid fever infection\u2013antibiotic resistance and vaccination strategies: a narrative review","volume":"40","author":"Masuet-Aumatell","year":"2021","journal-title":"J Travel Med Infect Dis"},{"key":"10.1016\/j.idnow.2022.03.001_bib0365","series-title":"Prise en charge de infections cutan\u00e9e bact\u00e9riennes courantes. Recommandation de la soci\u00e9t\u00e9 Fran\u00e7aise de Dematologie (SFD) et de la Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise (Spilf)","year":"2019"},{"key":"10.1016\/j.idnow.2022.03.001_bib0370","unstructured":"Prise en charge des plaies en structure d\u2019urgence. Recommandations de Bonnes Pratiques. Soci\u00e9t\u00e9 Fran\u00e7aise de Medecine d\u2019Urgence (SFMU) et Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise (Spilf). http:\/\/www.sfmu.org\/upload\/consensus\/rbp\/plaies2017v2. Consult\u00e9 le 8 septembre 2021."},{"key":"10.1016\/j.idnow.2022.03.001_bib0375","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice Guidelines for the diagnosis and management of skin and soft tissue infections: 2014. Update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2022.03.001_bib0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually Transmitted Infections Treatment Guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.idnow.2022.03.001_bib0380","unstructured":"Recommandations diagnostiques et th\u00e9rapeutiques pour les maladies Sexuellement transmissibles. Soci\u00e9t\u00e9 fran\u00e7aise de Dermatologie (SFD) 206. https:\/\/www.cnr-ist.fr\/ressources\/editeur\/Guidelines%20IST%20SFDermato%202016. Consult\u00e9 le 14 septembre 2021."},{"key":"10.1016\/j.idnow.2022.03.001_bib0385","first-page":"ciab044","article-title":"Effective treatment of lymphogranuloma venereum proctitis with azithromycin","author":"Blanco","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2022.03.001_bib0390","doi-asserted-by":"crossref","DOI":"10.1177\/09564624211023025","article-title":"Update on French recommendations for the treatment of uncomplicated Neisseria gonorrhoeae infections","author":"Fou\u00e9r\u00e9","year":"2021","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.idnow.2022.03.001_bib0470","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020","volume":"69","author":"St Cyr","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idnow.2022.03.001_bib0400","doi-asserted-by":"crossref","DOI":"10.1177\/0956462420949126","article-title":"European guideline for the diagnosis and treatment or gonorrhea in adults","author":"Unemo","year":"2020","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.idnow.2022.03.001_bib0405","series-title":"Guidelines for the Treatment of Neisseria gonorrhoeae","author":"WHO","year":"2016"},{"key":"10.1016\/j.idnow.2022.03.001_bib0410","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1177\/0956462419825948","article-title":"British Association for Sexual Health and HIV national guidelines for the management of infection with Mycoplasma genitalum (2018)","volume":"30","author":"Soni","year":"2019","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.idnow.2022.03.001_bib0415","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17972","article-title":"2021 European guideline on the management of Mycoplasma genitalium infections","author":"Jensen","year":"2022","journal-title":"Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.idnow.2022.03.001_bib0420","series-title":"Mise au point: Antibioth\u00e9rapie par voie g\u00e9n\u00e9rale dans les infections respiratoires basses de l\u2019adulte (Pneumonie aigu\u00eb communautaire-Exacerbations de Bronchopneumopathie Chronique Obstructive)","year":"2021"},{"key":"10.1016\/j.idnow.2022.03.001_bib0425","series-title":"Traitement antibiotique de la l\u00e9gionellose chez l\u2019adulte\u00a0: actualisation","year":"2021"},{"key":"10.1016\/j.idnow.2022.03.001_bib0430","series-title":"Guideline for the management of CAP in adults (2009). Summary of recommendations","year":"2015"},{"key":"10.1016\/j.idnow.2022.03.001_bib0435","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idnow.2022.03.001_bib0440","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0929-693X(17)30513-4","article-title":"Antibiotic treatment of lower respiratory tract infections","volume":"24","author":"Cohen","year":"2017","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.idnow.2022.03.001_bib0445","series-title":"Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing National Institute for Health and Care Excellence (NICE)","year":"2018"},{"key":"10.1016\/j.idnow.2022.03.001_bib0450","series-title":"Conduite \u00e0 tenir devant un ou plusieurs cas de coqueluche","year":"2014"},{"key":"10.1016\/j.idnow.2022.03.001_bib0455","unstructured":"Pertinence des actes et prescriptions m\u00e9dicamenteuses chez un patient adulte infect\u00e9 par Helicobacter pylori. http:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2017. Consult\u00e9 le 8 septembre 2021."},{"key":"10.1016\/j.idnow.2022.03.001_bib0460","first-page":"157","article-title":"Recommandations sur le traitement de l\u2019infection \u00e0 Helicobacter pylori chez l\u2019adulte","volume":"24","author":"Lamarque","year":"2017","journal-title":"Hepato Gastro"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991922000616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991922000616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:38:31Z","timestamp":1789472311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991922000616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2666991922000616"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2022.03.001","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization of macrolides. State of the art 2022 Spilf and GPIP","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2022.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}